Last reviewed · How we verify

NCT05641818

Challenges in Achieving Adequate Vitamin D Status in the Adult Population - Part 3 (VITAD/3)

Status unknown Last updated 14 December 2022
What this trial tests

trial testing Screening tool for vitamin D deficiency in Vitamin D Serum Levels in 400 participants. Status unknown.

Timeline
5 December 2022
Primary endpoint
1 October 2023
1 December 2023

Quick facts

Lead sponsorInstitute of Nutrition, Slovenia (Nutris)
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date5 December 2022
Primary completion1 October 2023
Estimated completion1 December 2023
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

Institute of Nutrition, Slovenia (Nutris)

Who can join

Adults 18 to 65, any sex, with Vitamin D Serum Levels. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Validation of a screening tool for identification of subjects at risk for suboptimal vitamin D status. Developed questionnaire-based screening tool will be used on subjects with various risks for vitamin D deficiency, and compared with 25-OH-vitamin D levels.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Institute of Nutrition, Slovenia (Nutris) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641818.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing